Long-term oral treatment of urinary tract infections with single daily doses of a new antibacterial drug combination (Kelfiprim)
✍ Scribed by von Niederhäusern, W. ;Boillat, J.-J. ;Petrescu, D. ;Groppi, W. ;Fanfani, A. ;Mandelli, V.
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 374 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
✦ Synopsis
Of 30 patients with severe, complicated U.T.I. 27 have been given single daily doses of Kelfiprim (KP), a new sulfatrimethoprim combination, for 8 weeks. In 24 bacteriuria was lastingly controlled, one had a relapse, one had a reinfection, and in one, with bladder carcinoma, bacteriuria persisted. Three other patients received KP for shorter periods, as they presented gastric intolerance or skin hypersensitivity, but in two of them a lasting sterilization of the urine has been obtained. The usefulness of a single daily dose schedule is stressed.